Profile

Suzanne Craft, Ph.D.Wake Forest School of Medicine

Suzanne Craft, Ph.D.

Professor,

Ctr for Vaccines at Extremes

Contact Information

Academic: 336-713-8830 | Department: 336-713-8570

Education & Training

  • B.A., University of Virginia, 1976
  • Ph.D., University of Texas-Austin, 1985
  • Internship, Clinical Neuropsychology, V.A. Medical Center(Boston), 1985
  • Fellowship, Neuropsychology, Boston University School of Me, 1986
  • Fellowship, Neuropsychology, Harvard Medical School, 1987

Memberships

  • Society for Neuroscience
  • Cognitive Neuro Soc
  • Int'l Neuropsychological Soc
Suzanne Craft, Ph.D.

Suzanne Craft, Ph.D.

Professor, Gerontology and Geriatric Medicine
Center on Diabetes, Obesity, and Metabolism
Ctr for Vaccines at Extremes

Research Interests

Alzheimer Disease; Insulin; Cognition Disorders; Insulin Resistance; Hypoglycemic Agents
More »

Contact Information

Academic: 336-713-8830 | Department: 336-713-8570

Recent Publications

The role of insulin in the vascular contributions to age-related dementia. Hughes TM, Craft S.. Biochim Biophys Acta. 2016;1862(5):983-991.

Apolipoprotein E genotype and sex influence glucose tolerance in older adults: a cross-sectional study. Hanson AJ, Banks WA, Hernandez Saucedo H, Craft S.. Dement Geriatr Cogn Dis Extra. 2016;6(1):78-89.

The aging vervet as a model of Alzheimer's disease [abstract]. Latimer C, Kaplan J, Shively C, Cline J, Andrews R, Jorgensen M, Craft S, Montine T, Keene C.. J Neuropathol Exp Neurol. 2016;75(6):604.

Sex biology contributions to vulnerability to Alzheimer's disease: a think tank convened by the Women's Alzheimer's Research Initiative. Snyder HM, Asthana S, Bain L, Brinton R, Craft S, Dubal DB, Espeland MA, Gatz M, Mielke MM, Raber J, Rapp PR, Yaffe K, Carrillo MC.. Alzheimers Dement. 2016;12(11):1186-1196.

Muscle heat shock protein 70 predicts insulin resistance with aging. Chichester L, Wylie AT, Craft S, Kavanagh K.. J Gerontol A Biol Sci Med Sci. 2015;70(2):155-162.

Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Willette AA, Johnson SC, Birdsill AC, Sager MA, Christian B, Baker LD, Craft S, Oh J, Statz E, Hermann BP, Jonaitis EM, Koscik RL, La Rue A, Asthana S, Bendlin BB.. Alzheimers Dement. 2015;11(5):504-510.e1.

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S.. J Alzheimers Dis. 2015;44(3):897-906.

The APOE genotype: modification of therapeutic responses in Alzheimer's disease. Hanson AJ, Craft S, Banks WA.. Curr Pharm Des. 2015;21(1):114-120.

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC.. Alzheimers Dement. 2015;11(6):710-717.

Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. Hughes TM, Craft S, Lopez OL.. Neurodegener Dis Manag. 2015;5(2):121-135.

Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Espeland MA, Brinton RD, Manson JE, Yaffe K, Hugenschmidt C, Vaughan L, Craft S, Edwards BJ, Casanova R, Masaki K, Resnick SM.. Neurology. 2015;85(13):1131-1138.

Mild cognitive impairment (MCI) in chemotherapy-treated breast cancer survivors [abstract]. Gifford A, Lawrence J, Case D, Rapp S, Baker L, Craft S, Groteluschen DL, Klepin H, Lesser G, Naughton MJ, Sachs B, Samuel TA, Sink K, Williamson, J, Shaw EG.. J Clin Oncol. 2015;33(15 Suppl):9560.

Differential effects of meal challenges on cognition, metabolism, and biomarkers for apolipoprotein E varepsilon4 carriers and adults with mild cognitive impairment. Hanson AJ, Bayer JL, Baker LD, Cholerton B, VanFossen B, Trittschuh E, Rissman RA, Donohue MC, Moghadam SH, Plymate SR, Craft S.. J Alzheimers Dis. 2015;48(1):205-218.

Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker. Oh ES, Marano CM, Leoutsakos JM, Lee RW, Rissman RA, Smith GS, Craft S, Lyketsos CG.. Alzheimers Dement. 2015;1(3):311-315.

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS.. Neurology. 2015;85(16):1383-1391.

Impact of type 2 diabetes and postmenopausal hormone therapy on incidence of cognitive impairment in older women. Espeland MA, Brinton RD, Hugenschmidt C, Manson JE, Craft S, Yaffe K, Weitlauf J, Vaughan L, Johnson KC, Padula CB, Jackson RD, Resnick SM.. Diabetes Care. 2015;38(12):2316-2324.

Montreal cognitive assessment and modified mini mental state examination in African Americans. Sink KM, Craft S, Smith SC, Maldjian JA, Bowden DW, Xu J, Freedman BI, Divers J.. J Aging Res. 2015;2015():872018.

Associations between markers of glucose and insulin function and cognitive function in healthy African American elders. Skinner JS, Morgan A, Hernandez-Saucedo H, Hansen A, Corbett S, Arbuckle M, Leverenz JB, Wilkins CH, Craft S, Baker LD.. J Gerontol Geriatr Res. 2015;4(4):.

Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Novak V, Milberg W, Hao Y, Munshi M, Novak P, Galica A, Manor B, Roberson P, Craft S, Abduljalil A.. Diabetes Care. 2014;37(3):751-759.

APOE genotype and gender influence glucose tolerance in older adults [abstract]. Hanson AJ, Hernandez H, Bartholomew LM, Gabrile AK, Chapman D, Craft S.. J Am Geriatr Soc. 2013;61(Suppl 1):S114.

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S.. J Alzheimers Dis. 2013;35(4):789-797.

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. Freiherr J, Hallschmid M, Frey WH 2nd, Brunner YF, Chapman CD, Holscher C, Craft S, De Felice FG, Benedict C.. CNS Drugs. 2013;27(7):505-514.

Neuropathologic correlates of cognition in a population-based sample. Cholerton B, Larson EB, Baker LD, Craft S, Crane PK, Millard SP, Sonnen JA, Montine TJ.. J Alzheimers Dis. 2013;36(4):699-709.

Glucose levels and risk of dementia. Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB.. N Engl J Med. 2013;369(6):540-548.

Intranasal treatment of central nervous system dysfunction in humans. Chapman CD, Frey WH II, Craft S, Danielyan L, Hallschmid M, Schioth HB, Benedict C.. Pharm Res. 2013;30(10):2475-2484.

Comparison of Montreal Cognitive Assessment (MOCA) and 3MSE scores in African-Americans [abstract]. Craft S, Smith C, Maldjian J, Freedman BI, Divers J.. Alzheimers Dement. 2013;9(4 Suppl):P321.

Aerobic exercise effects on cognition in at-risk adults: role of insulin sensitivity and APOE-epsilon 4 [abstract]. Baker L, Craft S, Cholerton B, Wilkinson C, Foster-Schubert K, McTiernan A, Williamson J, Sink K, Duncan G.. Alzheimers Dement. 2013;9(4 Suppl):P690.

Insulin, cognition, and dementia. Cholerton B, Baker LD, Craft S.. Eur J Pharmacol. 2013;719(1-3):170-179.

Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Tsai E, Postupna N, Zhang J, Lampe J, Craft S.. JAMA Neurol. 2013;70(8):972-980.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Suzanne Craft, Ph.D.

Suzanne Craft, Ph.D.

Professor, Gerontology and Geriatric Medicine
Center on Diabetes, Obesity, and Metabolism
Ctr for Vaccines at Extremes

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.